Virtus Investment Advisers’s Tourmaline Bio TRML Stock Holding History

Virtus Investment Advisers’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,718	Closed	-$273K	–	541
2025 Q3	$273K	Buy	5,718 +993	+21%	+$27.5K	0.08%	243
2025 Q2	$75.6K	Sell	4,725 -2,564	-35%	-$41.5K	0.03%	431
2025 Q1	$111K	Buy	+7,289	New	+$117K	0.03%	405

Virtus Investment Advisers's TRML Position: Q4 2025 in Review

Virtus Investment Advisers sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 5,718 shares — an estimated $273K sold.

Virtus Investment Advisers first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $273K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Virtus Investment Advisers reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Virtus Investment Advisers sold 5,718 Tourmaline Bio shares in Q4 2025, an estimated $273K.
Virtus Investment Advisers first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
Virtus Investment Advisers's Tourmaline Bio position peaked at $273K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.